Literature DB >> 4187085

The effect of disodium cromoglycate and other inhibitors on in vitro anaphylactic histamine release from guinea pig basophil leucocytes.

M W Greaves.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4187085     DOI: 10.1159/000230768

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


× No keyword cloud information.
  8 in total

1.  Inhibition of C5a-induced basophil degranulation by disodium cromoglycate.

Authors:  H W Golden; D A Iacuzio; I G Otterness
Journal:  Agents Actions       Date:  1987-08

Review 2.  Ocular sodium cromoglycate. An overview of its therapeutic efficacy in allergic eye disease.

Authors:  E M Sorkin; A Ward
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

3.  IgE-mediated hypersensitivity in human skin studied using a new in vitro method.

Authors:  M W Greaves; S Yamamoto; V M Fairley
Journal:  Immunology       Date:  1972-08       Impact factor: 7.397

4.  Comparison of in vivo and in vitro inhibition of the anaphylactic mechanism by beta-adrenergic stimulants and disodium cromoglycate.

Authors:  E S Assem; A W Richter
Journal:  Immunology       Date:  1971-11       Impact factor: 7.397

5.  Studies on passive cutaneous anaphylaxis in the rat with disodium cromoglycate. I. Cutaneous reactions induced by an anti-DNP 7S-gamma-2 antibody.

Authors:  T S Orr; J Gwilliam; J S Cox
Journal:  Immunology       Date:  1970-09       Impact factor: 7.397

Review 6.  Cromolyn.

Authors:  B A Berman; R N Ross
Journal:  Clin Rev Allergy       Date:  1983-03

7.  Systemic mastocytosis: control of lifelong diarrhea by ingested disodium cromoglycate.

Authors:  J Dolovich; N D Punthakee; A B MacMillan; G J Osbaldeston
Journal:  Can Med Assoc J       Date:  1974-10-05       Impact factor: 8.262

Review 8.  Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1974       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.